The Wall Street Journal publishes a second piece on Theranos, this time reporting that the FDA views its “nanotainer,” a small capsule that it uses to collect samples, as an unapproved medical device. In response, Theranos quietly stopped using its finger-stick testing process on all but one test, and now instead uses traditional methods to collect and process the hundreds of other tests it offers.
During a visit to the company’s Palo Alto campus, SAP CEO Bill McDermott discusses a recent accident that left him blind in one eye, using the story to point out health IT inefficiencies he noticed from the perspective of a patient, explaining “In every single meeting, you have to repeat the entire story all over again, because there’s no one electronic medical record that comes before you — or follows you — throughout a case.” He calls the doctors who treated him amazing, though “unstructured in their behavior.”
A local Madison, WI paper covers a sexual harassment complaint filed by the former Nordic VP of Marketing against the company president, Drew Madden. The complaint, which will be heard this week before the city’s Equal Opportunities Division, alleges that the former VP was “sexually harassed by her supervisor, the president and co-owner of Nordic, and then discharged in retaliation for reporting the harassment.”
In Canada, Alberta’s Privacy Commission calls data breaches an epidemic after discovering that 48 employees at Calgary’s South Health Campus were inappropriately accessing a patient’s record.